Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK-Reference-Cited by-同舟云学术

Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK

Published:2011-06 Issue:6 Volume:19 Page:1131-1140
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Di Paolo Daniela,Brignole Chiara,Pastorino Fabio,Carosio Roberta,Zorzoli Alessia,Rossi Marzia,Loi Monica,Pagnan Gabriella,Emionite Laura,Cilli Michele,Bruno Silvia,Chiarle Roberto,Allen Theresa M,Ponzoni Mirco,Perri Patrizia

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Identification of ALK as a major familial neuroblastoma predisposition gene;Mossé;Nature,2008

2. Oncogenic mutations of ALK kinase in neuroblastoma;Chen;Nature,2008

3. Activating mutations in ALK provide a therapeutic target in neuroblastoma;George;Nature,2008

4. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma;Janoueix-Lerosey;Nature,2008

5. High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours;Carén;Biochem J,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting pediatric solid tumors in the new era of RNA therapeutics;Critical Reviews in Oncology/Hematology;2024-08

2. GD2-targeting therapy: a comparative analysis of approaches and promising directions;Frontiers in Immunology;2024-03-15

3. Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications;3 Biotech;2024-01-29

4. Therapeutic silencing of mTOR by systemically administered siRNA-loaded neutral liposomal nanoparticles inhibits DMBA-induced mammary carcinogenesis;British Journal of Cancer;2022-10-19

5. Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma;Frontiers in Pharmacology;2022-06-02